GLP-1 medications have quickly become one of the biggest topics in employer healthcare, driving new questions around cost, coverage, and value. As demand rises and obesity rates continue to climb, employers are under increasing pressure to decide whether to cover these drugs for weight loss. With spending growing fast, a clear strategy is essential to balance member needs, clinical outcomes, and long-term plan costs.

Related insights

Flyers

By Popular Demand: GLP-1s, Benefit Plans, and the Pressure to Cover

GLP-1 medications have quickly become one of the biggest topics in employer healthcare, driving new questions around cost, coverage, and value. As demand rises and obesity rates continue to climb, employers are under increasing pressure to decide whether to cover these drugs for weight loss. With spending growing fast, ...

Blogs

What to do if your renewal comes back higher than expected

If you’re preparing for January renewals, October can feel like the moment of truth. With renewal information arriving in the fall and analysts anticipating a 9% increase in medical expenses, many employers may see a renewal proposal that comes in higher than expected. When that happens, the good news ...

Blogs

3 ways social inflation is changing liability risk for senior living communities

For senior living owners and operators, liability claims are becoming harder to predict and more expensive to resolve. One reason is social inflation — the rise in claim costs, settlement demands, and jury awards beyond normal inflation. In practical terms, an incident that may have been manageable a few ...

More Insights